|
Veterinary Diagnostics: COVID-19 Pandemic Can't Slow Momentum of $3.5 Billion Market
Thursday, March 17, 2022
Healthcare publisher, Kalorama Information, shares insights from its latest report on the Veterinary Diagnostics market.
ARLINGTON, Va., March 9, 2022 /PRNewswire-PRWeb/ -- The veterinary diagnostics market has experienced steady growth through the ravages of the pandemic and is forecast to produce continued growth in coming years, according to analysis in The World Market for Veterinary Diagnostics, 5th Edition, a new report from Kalorama Information, a leading medical market research firm.
The global veterinary diagnostics market's revenues of $3.5 billion in 2021 reflect a growing demand for companion animal diagnostics (pets and domestic animals including horses) followed by the steady performance of the food animal segment (livestock and production animal). Ultimately, the market is expected to experience a compound annual growth rate (CAGR) of 7.7% from 2021-2026. Note that diagnostic revenues in the report do not include imaging diagnostics.
The veterinary diagnostics market represents a relatively fast-growing opportunity to in-vitro diagnostic (IVD) companies and others able to capitalize on the unfailing need to ensure agricultural productivity and the growth in consumer spending on companion animals. Companies enter the veterinary diagnostics market through acquisitions, product development, and licensing or OEM agreements. Low barriers to market entry and a lack of insurmountable competition makes superior rates of growth in certain segments of the veterinary diagnostics market realizable for a broad range of companies.
IVD instrumentation and products have been extensively applied to veterinary healthcare as various assay forms, analytes and analyzers are transferrable from the clinical space to the veterinary clinic and laboratory. The veterinary diagnostics market also supports many test markets related to animal-specific diseases (e.g., bluetongue disease, classical swine fever, feline leukemia) and zoonotic diseases (or diseases capable of being transmitted from animals to humans such as influenza, transmissible spongiform encephalopathies, and brucellosis).
Veterinary diagnostics comprehensively support animal health, through:
-- routine testing of companion animals during clinical visits or
check-ups;
-- diagnosis of disease in symptomatic companion animals;
-- zoonotic disease surveillance in wildlife populations;
-- disease screening and confirmatory testing in livestock and production
animals as part of disease control efforts.
International trade, public health, agricultural productivity, consumer confidence and companion animal-owner relationships are all dependent upon effective and increasingly specialized veterinary diagnostics products. Expertise in molecular diagnostics, virology and bacteriology is crucial in the food animal (livestock and production animal) diagnostics space as emergent threats and outbreaks necessitate the development and improvement of assays for newly implemented disease control programs. Technical barriers to entry in the lucrative companion animal diagnostics space are relatively low. Many market participants in companion animal diagnostics have adapted clinical diagnostic analyzers - hematology analyzers or blood counters, chemistry analyzers, critical care analyzers - with modifications limited mostly to reference ranges, sample preparation and some parameters.
For more information or to purchase The World Market for Veterinary Diagnostics, 5th Edition visit: https://kaloramainformation.com/product/the-world-market-for-veterinary-diagnostics-5th-edition/.
About Kalorama Information:
Kalorama Information, part of Science and Medicine Group, is the leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, medical devices, and pharmaceuticals. Science and Medicine Group supports companies seeking to commercialize the rapidly changing marketplace at the intersection of science, medicine, and technology. Comprised of industry-leading brands, Science and Medicine Group serves analytical instrument, life science, imaging, and clinical diagnostic companies by helping them create strategies and products to win markets and provide platforms to digitally engage their markets through a variety of innovative solutions. Kalorama Information produces 30 reports a year. The firm offers a Knowledge Center, which provides access to all published reports.
Media Contact
Bruce Carlson, Kalorama Information, 703-783-1747, bruce.carlson@kaloramainformation.com
SOURCE Kalorama Information
|
|
|
|
|
|
 |
The New Identity Theft Crisis: AI Scams, Child Victims, and Credit Damage Are All Spiking | Jan 22, 2026
|
|
AllSci Launches Hypothesis Publishing: A Seamless Way to Share, Connect, and Advance Scientific Ideas | Jan 22, 2026
|
|
Canadian Fintech Tuhk Inc., Founded by Ethoca and NuData Security Veterans, Raises US$6 Million Seed Round Led by FINTOP, with Lloyds Banking Group and Capital One Ventures | Jan 22, 2026
|
|
Fintech Startup BON Credit Secures $3.5 Million In Funding | Jan 22, 2026
|
|
Darwin CX Caps a Banner Year with AI Launch, Sold-Out Events, and Industry Book Launch | Jan 22, 2026
|
|
Nudge Security Unveils Industry's Most Comprehensive AI Security Governance Platform | Jan 22, 2026
|
|
PayDo Launches Unified Payment Infrastructure Suite for Digital Businesses | Jan 22, 2026
|
|
TSX Venture Exchange Market Data Now Available Across Over 40 Blockchains via Chainlink | Jan 22, 2026
|
|
IoTeX Publishes MiCA-Compliant Whitepaper for IOTX, Enabling EU-Wide Alignment Under the New Regulatory Framework | Jan 22, 2026
|
|
Paxos Selects Mesh To Enable Trusted Crypto Deposits | Jan 22, 2026
|
|
|
|
